Risk of gastrointestinal complications in breast cancer patients treated with neratinib: a meta-analysis.
Jiang N, Song XW, Lin JJ, Wang ZY, Zhang BN, Li A, Yan RY, Yan HF, Fu XY, Zhou JL, Li CL, Cui Y.
Jiang N, et al. Among authors: li a, li cl.
Expert Opin Drug Saf. 2017 Oct;16(10):1111-1119. doi: 10.1080/14740338.2017.1354986. Epub 2017 Aug 2.
Expert Opin Drug Saf. 2017.
PMID: 28766379